Yuichiro Shindo

2.8k total citations
55 papers, 1.3k citations indexed

About

Yuichiro Shindo is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Yuichiro Shindo has authored 55 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Epidemiology, 18 papers in Pulmonary and Respiratory Medicine and 17 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Yuichiro Shindo's work include Pneumonia and Respiratory Infections (27 papers), Nosocomial Infections in ICU (15 papers) and Pneumocystis jirovecii pneumonia detection and treatment (10 papers). Yuichiro Shindo is often cited by papers focused on Pneumonia and Respiratory Infections (27 papers), Nosocomial Infections in ICU (15 papers) and Pneumocystis jirovecii pneumonia detection and treatment (10 papers). Yuichiro Shindo collaborates with scholars based in Japan, United States and Italy. Yuichiro Shindo's co-authors include Yoshinori Hasegawa, Kazuyoshi Imaizumi, Richard S. Hotchkiss, Eiichi Maruyama, Shinji Sato, Takamasa Ohashi, Masahiro Ogawa, Naozumi Hashimoto, Tosiya Sato and Jacqueline Unsinger and has published in prestigious journals such as PLoS ONE, Scientific Reports and CHEST Journal.

In The Last Decade

Yuichiro Shindo

51 papers receiving 1.3k citations

Peers

Yuichiro Shindo
Yuichiro Shindo
Citations per year, relative to Yuichiro Shindo Yuichiro Shindo (= 1×) peers Antoni Torres

Countries citing papers authored by Yuichiro Shindo

Since Specialization
Citations

This map shows the geographic impact of Yuichiro Shindo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuichiro Shindo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuichiro Shindo more than expected).

Fields of papers citing papers by Yuichiro Shindo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuichiro Shindo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuichiro Shindo. The network helps show where Yuichiro Shindo may publish in the future.

Co-authorship network of co-authors of Yuichiro Shindo

This figure shows the co-authorship network connecting the top 25 collaborators of Yuichiro Shindo. A scholar is included among the top collaborators of Yuichiro Shindo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuichiro Shindo. Yuichiro Shindo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takeuchi, Suguru, Jun‐ichi Kawada, Atsushi Suzuki, et al.. (2025). Metagenomic Analysis of Lung Microbiome in Patients With Interstitial Lung Diseases and Sarcoidosis: An Experimental Study. Health Science Reports. 8(2). e70328–e70328. 2 indexed citations
2.
Mukae, Hiroshi, Naoki Iwanaga, Nobuyuki Horita, et al.. (2025). The JRS guideline for the management of pneumonia in adults 2024. Respiratory Investigation. 63(5). 811–828. 1 indexed citations
3.
Kato, Sayaka, Koji Sakamoto, Yuichiro Shindo, et al.. (2024). Rapidly progressive interstitial lung disease with positive anti-MDA5 antibody as an immune-related complication of nivolumab: A case report. Respiratory Investigation. 62(2). 313–316. 1 indexed citations
4.
Sano, Masahiro, Yuichiro Shindo, Kunihiko Takahashi, et al.. (2022). Risk factors for antibiotic resistance in hospital-acquired and ventilator-associated pneumonia. Journal of Infection and Chemotherapy. 28(6). 745–752. 4 indexed citations
5.
Hiramatsu, Mariko, Naoki Nishio, Masayuki Ozaki, et al.. (2020). Anesthetic and surgical management of tracheostomy in a patient with COVID-19. Auris Nasus Larynx. 47(3). 472–476. 15 indexed citations
6.
Pletz, Mathias W., Francesco Blasi, James D. Chalmers, et al.. (2020). International Perspective on the New 2019 American Thoracic Society/Infectious Diseases Society of America Community-Acquired Pneumonia Guideline. CHEST Journal. 158(5). 1912–1918. 40 indexed citations
7.
Nishio, Naoki, Mariko Hiramatsu, Yukari Goto, et al.. (2020). Surgical strategy and optimal timing of tracheostomy in patients with COVID-19: Early experiences in Japan. Auris Nasus Larynx. 48(3). 518–524. 11 indexed citations
8.
Miyazaki, Taiga, Katsunori Yanagihara, Hiroshi Kakeya, et al.. (2019). Daily practice and prognostic factors for pneumonia caused by methicillin-resistant Staphylococcus aureus in Japan: A multicenter prospective observational cohort study. Journal of Infection and Chemotherapy. 26(2). 242–251. 3 indexed citations
9.
Okumura, Junya, Yoshio Nakahara, Masato Nakaguro, et al.. (2019). BK virus-associated viruria and viremia in a patient with lymphangioleiomyomatosis after lung re-transplantation: A case report and review of the literature on BK virus infection post-lung transplantation. Journal of Infection and Chemotherapy. 25(10). 820–824. 1 indexed citations
10.
Okumura, Junya, Yuichiro Shindo, Kunihiko Takahashi, et al.. (2017). Mortality in patients with community‐onset pneumonia at low risk of drug‐resistant pathogens: Impact of β‐lactam plus macrolide combination therapy. Respirology. 23(5). 526–534. 15 indexed citations
11.
Sibila, Oriol, Ana Rodrigo‐Troyano, Yuichiro Shindo, Stefano Aliberti, & Marcos I. Restrepo. (2016). Multidrug-resistant pathogens in patients with pneumonia coming from the community. Current Opinion in Pulmonary Medicine. 22(3). 219–226. 26 indexed citations
12.
13.
Imaizumi, Kazuyoshi, Izumi Hashimoto, Yuichiro Shindo, et al.. (2013). Prospective analysis of efficacy and safety of an individualized-midazolam-dosing protocol for sedation during prolonged bronchoscopy. Respiratory Investigation. 52(3). 153–159. 22 indexed citations
14.
Kohno, Shigeru, Yoshifumi Imamura, Yuichiro Shindo, et al.. (2013). Clinical Practice Guidelines for Nursing- and Healthcare-associated Pneumonia (NHCAP) [Complete translation]. Respiratory Investigation. 51(2). 103–126. 135 indexed citations
15.
Falcone, Marco, Mario Venditti, Yuichiro Shindo, & Marin H. Kollef. (2011). Healthcare-associated pneumonia: Diagnostic criteria and distinction from community-acquired pneumonia. International Journal of Infectious Diseases. 15(8). e545–e550. 52 indexed citations
16.
Matsumura, Yasufumi, Yuichiro Shindo, Yoshitsugu Iinuma, et al.. (2011). Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes. BMC Infectious Diseases. 11(1). 76–76. 80 indexed citations
17.
Ichikawa, Motoshi, Ryujiro Suzuki, Kensuke Kataoka, et al.. (2010). Second-line weekly paclitaxel in resistant or relapsed non-small cell lung cancer treated with docetaxel and carboplatin: A multi-center phase II study. Lung Cancer. 69(3). 319–322. 6 indexed citations
18.
Shindo, Yuichiro, Shinji Sato, Eiichi Maruyama, et al.. (2008). Health-Care-Associated Pneumonia Among Hospitalized Patients in a Japanese Community Hospital. CHEST Journal. 135(3). 633–640. 200 indexed citations
19.
Shindo, Yuichiro, Shinji Sato, Eiichi Maruyama, et al.. (2008). Comparison of severity scoring systems A‐DROP and CURB‐65 for community‐acquired pneumonia. Respirology. 13(5). 731–735. 114 indexed citations
20.
Shindo, Yuichiro, et al.. (1988). Subcutaneous sarcoidosis with extensive caseation necrosis. Journal of Cutaneous Pathology. 15(3). 188–190. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026